Advertisement: Simpsons Creative
Advertisement: RSM mid banner
Advertisement: CJBS mid banner
Advertisement: partnersand mid banner
Cambridgeand mid banner advertisement
Barr Ellison Solicitors – commercial property
Advertisement: Kao Data Centre mid banner
Advertisement: Bar Ellison mid banner property
Advertisement: EBCam mid banner
ARM Innovation Hub
Advertisement mid banner S-Tech 1
Advertisement: Cambridge Network mid banner
Advertisement: Excalibur Healthcare mid banner
Advertisement: Mogrify mid banner
Mid banner advertisement: BDO
Advertisement: HCR Hewitsons mid banner
Advertisement: SATAVIA mid banner
24 January, 2022 - 10:39 By Tony Quested

Webinars outline new Cambridge Biomedical Cluster Map and Report

The most comprehensive map of the Cambridge Biomedical Cluster ever produced has its soft launch tomorrow (Tuesday), Wednesday and Thursday with webinars masterminded by the brains behind the initiative, Jeanette Walker.

How many biomedical companies are located in Cambridge UK? How many are engaged in the discovery of new medicines? What platform technologies, products and services are being developed by companies in the Cambridge cluster? Where are they located? How important are science parks?

These are just some of the questions addressed in the 2022 edition of the report and accompanying map.

At this free webinar, report author Jeanette Walker will present a snapshot of the cluster as at January 2022.

The event details are as follows: 

  • Tuesday, 25 January 2022 12:30 
  • Wednesday, 26 January 2022 15:30 
  • Thursday, 27 January 2022 09:00 

To take part please go to https://www.eventbrite.co.uk/e/2022-cambridge-biomedical-cluster-map-report-launch-event-tickets-245445984547

The launch is in collaboration with map sponsor Brockton Everlast, which is a London-based real estate investment and development firm, dedicated to providing life science focused laboratories and workplaces around the Golden Triangle of London, Cambridge and Oxford. 

Business Weekly has agreed to be media partner for the Cambridge Biomedical Cluster Map and Report and associated spin-out initiatives.

Walker, formerly with ERBI, helped the University of Cambridge produce the first such map back in 2007. She updated the initiative in 2013 and 2014 and has incorporated a number of updates, first in 2015 and now in the 2022 iteration.

Walker, who also acted as marketing guru for the then vacant Cambridge Biomedical Campus and went on to become director of Cambridge Science Park, says the initial focus of the map and report on companies in  pharma, biotech and their supply chains has been considerably broadened and enhanced. One major feature is an analysis of the companies on the map.

The 2022 version of the map and associated analysis includes medical technology innovators as well as players involved in pharma, biotech and the supply chain. The cluster map focuses on companies gated within a 20-mile radius of Great St Marys.

About the sponsor

Brockton Everlast is a London-based real estate investment and development firm with a focus on acquiring, developing and asset managing large scale buildings that provide some of the best and most sustainable workplaces across both the centre of London and its wider metro area. The company also provides life science-focused laboratories and workplaces in the specialised, world-leading clusters of Cambridge and Oxford. Brockton has a 16-year history that spans over 20m sq ft across 300 buildings and around £7.0bn ($9.5bn) of assets. It is focused on growing both its Workplace and SRI (‘Science, Real Estate + Innovation’) divisions.

Newsletter Subscription

Stay informed of the latest news and features